NYSE:USNA - USANA Health Sciences Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$131.10 +1.60 (+1.24 %)
(As of 08/20/2018 03:55 PM ET)
Previous Close$130.60
Today's Range$128.50 - $131.15
52-Week Range$55.50 - $137.95
Volume1,135 shs
Average Volume167,206 shs
Market Capitalization$3.15 billion
P/E Ratio31.81
Dividend YieldN/A
Beta0.73
USANA Health Sciences logoUSANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Sensé?beautiful science products, such as personal care products that support healthy skin and hair through topical nourishment, moisturization, and protection; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

Receive USNA News and Ratings via Email

Sign-up to receive the latest news and ratings for USNA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Medicinals & botanicals
Sub-IndustryPersonal Products
SectorMedical
SymbolNYSE:USNA
CUSIP90328M10
Phone801-954-7100

Debt

Debt-to-Equity RatioN/A
Current Ratio2.96
Quick Ratio2.42

Price-To-Earnings

Trailing P/E Ratio31.81
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.05 billion
Price / Sales3.04
Cash Flow$4.9009 per share
Price / Cash26.75
Book Value$15.14 per share
Price / Book8.66

Profitability

EPS (Most Recent Fiscal Year)$4.06
Net Income$62.53 million
Net Margins7.16%
Return on Equity29.50%
Return on Assets21.55%

Miscellaneous

Employees1,810
Outstanding Shares24,250,000
Market Cap$3.15 billion

USANA Health Sciences (NYSE:USNA) Frequently Asked Questions

What is USANA Health Sciences' stock symbol?

USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA."

How will USANA Health Sciences' stock buyback program work?

USANA Health Sciences declared that its board has authorized a share repurchase plan on Wednesday, July 26th 2017, which permits the company to buyback $64,600,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to purchase up to 46% of its shares through open market purchases. Shares buyback plans are typically a sign that the company's board of directors believes its shares are undervalued.

How were USANA Health Sciences' earnings last quarter?

USANA Health Sciences, Inc. (NYSE:USNA) announced its quarterly earnings data on Tuesday, July, 24th. The company reported $1.36 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.11 by $0.25. The company had revenue of $301.50 million for the quarter, compared to analyst estimates of $278.41 million. USANA Health Sciences had a net margin of 7.16% and a return on equity of 29.50%. The firm's quarterly revenue was up 17.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.98 earnings per share. View USANA Health Sciences' Earnings History.

When is USANA Health Sciences' next earnings date?

USANA Health Sciences is scheduled to release their next quarterly earnings announcement on Tuesday, October, 23rd 2018. View Earnings Estimates for USANA Health Sciences.

What guidance has USANA Health Sciences issued on next quarter's earnings?

USANA Health Sciences issued an update on its FY18 earnings guidance on Tuesday, July, 24th. The company provided earnings per share guidance of $4.75-5.05 for the period, compared to the Thomson Reuters consensus estimate of $4.56. The company issued revenue guidance of $1.15 billion, compared to the consensus revenue estimate of prior $4.25-4.55.

What price target have analysts set for USNA?

2 equities research analysts have issued 12-month price objectives for USANA Health Sciences' shares. Their predictions range from $135.00 to $135.00. On average, they anticipate USANA Health Sciences' stock price to reach $135.00 in the next year. This suggests a possible upside of 3.7% from the stock's current price. View Analyst Price Targets for USANA Health Sciences.

What is the consensus analysts' recommendation for USANA Health Sciences?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for USANA Health Sciences in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for USANA Health Sciences.

Who are some of USANA Health Sciences' key competitors?

Who are USANA Health Sciences' key executives?

USANA Health Sciences' management team includes the folowing people:
  • Dr. Myron W. Wentz, Founder & Chairman (Age 77)
  • Mr. Kevin G. Guest, CEO & Director (Age 55)
  • Mr. Jim Brown, Pres & COO (Age 49)
  • Mr. G. Douglas Hekking, Chief Financial Officer (Age 48)
  • Mr. Daniel A. Macuga Jr., Chief Communications & Marketing Officer (Age 48)

Has USANA Health Sciences been receiving favorable news coverage?

News articles about USNA stock have been trending somewhat positive on Monday, Accern Sentiment reports. The research group identifies positive and negative media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. USANA Health Sciences earned a media and rumor sentiment score of 0.07 on Accern's scale. They also assigned news headlines about the company an impact score of 45.74 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near term. View Recent Headlines for USANA Health Sciences.

Who are USANA Health Sciences' major shareholders?

USANA Health Sciences' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include WENTZ MYRON W (43.80%), Renaissance Technologies LLC (8.68%), BlackRock Inc. (3.98%), Acadian Asset Management LLC (3.71%), Dimensional Fund Advisors LP (3.00%) and FMR LLC (0.99%). Company insiders that own USANA Health Sciences stock include Daniel A Macuga, David Mulham Mulham, Deborah Woo, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, James Bramble, Jim Brown, Kevin Guest, Myron W Wentz, Paul A Jones, Robert Auciaux and Walter Noot. View Institutional Ownership Trends for USANA Health Sciences.

Which institutional investors are selling USANA Health Sciences stock?

USNA stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Schroder Investment Management Group, Dimensional Fund Advisors LP, Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp, Wells Fargo & Company MN, Cubist Systematic Strategies LLC, Mackay Shields LLC and Russell Investments Group Ltd.. Company insiders that have sold USANA Health Sciences company stock in the last year include Daniel A Macuga, David Mulham Mulham, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, James Bramble, Jim Brown, Kevin Guest, Myron W Wentz, Paul A Jones and Walter Noot. View Insider Buying and Selling for USANA Health Sciences.

Which institutional investors are buying USANA Health Sciences stock?

USNA stock was purchased by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Renaissance Technologies LLC, Robeco Institutional Asset Management B.V., BlackRock Inc., Millennium Management LLC, Federated Investors Inc. PA, Sensato Investors LLC and Caisse DE Depot ET Placement DU Quebec. View Insider Buying and Selling for USANA Health Sciences.

How do I buy shares of USANA Health Sciences?

Shares of USNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is USANA Health Sciences' stock price today?

One share of USNA stock can currently be purchased for approximately $130.20.

How big of a company is USANA Health Sciences?

USANA Health Sciences has a market capitalization of $3.15 billion and generates $1.05 billion in revenue each year. The company earns $62.53 million in net income (profit) each year or $4.06 on an earnings per share basis. USANA Health Sciences employs 1,810 workers across the globe.

How can I contact USANA Health Sciences?

USANA Health Sciences' mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The company can be reached via phone at 801-954-7100 or via email at [email protected]


MarketBeat Community Rating for USANA Health Sciences (NYSE USNA)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  205 (Vote Outperform)
Underperform Votes:  317 (Vote Underperform)
Total Votes:  522
MarketBeat's community ratings are surveys of what our community members think about USANA Health Sciences and other stocks. Vote "Outperform" if you believe USNA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe USNA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/20/2018 by MarketBeat.com Staff

Featured Article: NASDAQ

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel